# Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

> **NCT03147599** · PHASE4 · COMPLETED · sponsor: **Mansoura University** · enrollment: 110 (actual)

## Conditions studied

- Oncology
- Incontinence
- Incontinence, Daytime Urinary
- Incontinence, Nighttime Urinary
- Bladder Cancer
- Orthotopic Neobladder

## Interventions

- **DRUG:** Coloverin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03147599
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2020-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03147599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03147599, "Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03147599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*